Alkermes (ALKS) Short-term Investments (2011 - 2026)

Alkermes' (ALKS) quarterly Short-term Investments came in at $160.3 million in Q1 2026, down 66.89% year-on-year from $484.2 million in Q1 2025, and down 78.08% on a QoQ basis from $731.2 million in Q4 2025.

Alkermes (ALKS) Short-term Investments (2011 - 2026) Analysis & Trends

Alkermes (ALKS) has 16 years of Short-term Investments data on file, last reported at $160.3 million in Q1 2026.

  • On a quarterly basis, Short-term Investments fell 66.89% year-over-year to $160.3 million in Q1 2026; TTM through Mar 2026 was $160.3 million, a 66.89% decrease from a year earlier, with the FY2025 full-year figure at $731.2 million, up 58.78% from the prior year.
  • Short-term Investments for Q1 2026 stood at $160.3 million, down from $731.2 million in the prior quarter.
  • Over the last five years, Short-term Investments for ALKS reached as high as $731.2 million in Q4 2025 and fell as low as $160.3 million in Q1 2026.
  • Historically, Short-term Investments has averaged $365.2 million across 5 years, with a median of $324.3 million in 2024.
  • Across the five-year window, Short-term Investments jumped 112.3% in 2024 and sank 66.89% in 2026, its largest moves.
  • Year by year, Short-term Investments stood at $316.0 million in 2022, then gained by 0.01% to $316.0 million in 2023, then surged by 45.72% to $460.5 million in 2024, then surged by 58.78% to $731.2 million in 2025, then sank by 78.08% to $160.3 million in 2026.
  • Per Business Quant data, the three most recent Short-term Investments figures were $160.3 million in Q1 2026, $731.2 million in Q4 2025, and $494.7 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 87.22 Bn 85.35 Bn -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn
10 Alkermes 9.72 Bn 9.21 Bn 331.33 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 160.31 Mn
Dec 31, 2025 731.21 Mn
Sep 30, 2025 494.67 Mn
Jun 30, 2025 494.54 Mn
Mar 31, 2025 484.21 Mn
Dec 31, 2024 460.52 Mn
Sep 30, 2024 512.57 Mn
Jun 30, 2024 340.97 Mn
Mar 31, 2024 324.30 Mn
Dec 31, 2023 316.02 Mn
Sep 30, 2023 241.44 Mn
Jun 30, 2023 163.25 Mn
Mar 31, 2023 279.06 Mn
Dec 31, 2022 315.99 Mn
Sep 30, 2022 316.23 Mn
Jun 30, 2022 326.32 Mn
Mar 31, 2022 246.32 Mn
Dec 31, 2021 198.77 Mn
Sep 30, 2021 249.86 Mn
Jun 30, 2021 280.00 Mn